Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.3 HKD 0.3% Market Closed
Market Cap: 60.5B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sino Biopharmaceutical Ltd
Deferred Income Tax Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Deferred Income Tax
ÂĄ797.2m
CAGR 3-Years
1%
CAGR 5-Years
-13%
CAGR 10-Years
30%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Deferred Income Tax
HK$289.7m
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
20%
U
United Laboratories International Holdings Ltd
HKEX:3933
Deferred Income Tax
ÂĄ368.3m
CAGR 3-Years
37%
CAGR 5-Years
7%
CAGR 10-Years
-7%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Deferred Income Tax
ÂĄ1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
15%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Deferred Income Tax
HK$1.7B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sino Biopharmaceutical Ltd's Deferred Income Tax?
Deferred Income Tax
797.2m CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Deferred Income Tax amounts to 797.2m CNY.

What is Sino Biopharmaceutical Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
30%

Over the last year, the Deferred Income Tax growth was 28%. The average annual Deferred Income Tax growth rates for Sino Biopharmaceutical Ltd have been 1% over the past three years , -13% over the past five years , and 30% over the past ten years .

Back to Top